Cheol-Young Maeng

Title: **Cheol-Young Maeng: Innovating in Pharmaceutical Chemistry**

Introduction

Cheol-Young Maeng is a notable inventor based in Daejeon, South Korea, recognized for his contributions to pharmaceutical chemistry. With a remarkable portfolio of seven patents, Maeng has made significant advancements in the field, particularly focusing on compounds that influence dopamine reuptake.

Latest Patents

Among his latest innovations are the Aminocarbonylcarbamate compounds. These compounds are represented by a specific formula and include pharmaceutically acceptable salts that demonstrate effectiveness as dopamine reuptake inhibitors. The disclosure also details methods for using these compounds, highlighting their potential therapeutic applications in treating various neurological disorders.

Career Highlights

Cheol-Young Maeng has made substantial contributions while working with reputable companies in the industry, including SK Biopharmaceuticals Co., Ltd. and Aprogen Inc. His work in these organizations has allowed him to push the boundaries of pharmaceutical research and development, leading to innovative solutions that could benefit many patients.

Collaborations

Throughout his career, Maeng has collaborated with distinguished coworkers such as Young-Soon Kang and Jin-Yong Chung. These partnerships have fostered a rich exchange of ideas and have been pivotal in advancing their collective research in pharmaceutical sciences.

Conclusion

Cheol-Young Maeng continues to be an influential figure in the realm of pharmaceutical innovations. With his focus on dopamine reuptake inhibitors and a solid track record of patents, he demonstrates the importance of collaboration and creativity in the pursuit of scientific advancements that can significantly impact health and well-being.